UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053774
Receipt number R000060817
Scientific Title Clinical evaluation of composite resin restorations using the Clear Index Technique with digital technology.
Date of disclosure of the study information 2024/04/01
Last modified on 2024/09/13 20:36:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical evaluation of composite resin restorations using the Clear Index Technique with digital technology.

Acronym

Clinical evaluation of composite resin restorations using the Clear Index Technique with digital technology.

Scientific Title

Clinical evaluation of composite resin restorations using the Clear Index Technique with digital technology.

Scientific Title:Acronym

Clinical evaluation of composite resin restorations using the Clear Index Technique with digital technology.

Region

Japan


Condition

Condition

Dental caries, crown fracture, dwarf teeth, Missing tooth

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine what advantages the Clear Index technique, which utilises digital technology, offers in terms of quality and efficiency compared to traditional composite resin restoration methods.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of dimensional accuracy in composite resin restorations using the clear index technique in the experimental group and the conventional method in the control group.

Key secondary outcomes

Evaluating treatment time: measurement of the time required to treat composite resin restorations.
Esthetic assessment: surface gloss, colouration, tone and transparency, aesthetic anatomical morphology, material fracture and retention, etc.
Assessment of functional properties: margin fit, wear, patient opinion, presence of hypersensitivity, etc.
Assessment of biological characteristics: secondary caries, condition of periodontal tissue, condition of mucosa, oral and systemic health.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Composite resin restorations using the 'Clear Index Technique'. The 'index technique' is a restorative technique in which a clear index (transparent mould) is used, the flowable composite resin is loaded into the required area between the dentition and the dentition, and light-cured using a blue light LED irradiator.

Interventions/Control_2

Perform conventional composite resin restorations. Apply composite resin restorations according to standard operative procedures.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Individuals requiring composite resin restoration for permanent teeth.

Key exclusion criteria

Individuals with extremely poor oral hygiene.
Persons suffering from severe periodontitis in the entire jaw.
Those who are pregnant or breastfeeding.
Individuals with serious systemic diseases (such as severe diabetes, cardiovascular diseases).
Persons with a history of allergies (especially to resin materials or silicon).
Individuals deemed unable to participate in the study due to mental illnesses or dementia.
Others whom the principal investigator deems inappropriate for participation in the study.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Keiichi
Middle name
Last name Hosaka

Organization

Tokushima University Graduate School

Division name

Institute of Biomedical Sciences

Zip code

770-8504

Address

3-18-15 Kuramoto-cho, Tokushima

TEL

088-633-7340

Email

hosaka@tokushima-u.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Takegawa

Organization

Tokushima University Graduate School

Division name

Institute of Biomedical Sciences

Zip code

770-8504

Address

3-18-15 Kuramoto-cho, Tokushima

TEL

088-633-7340

Homepage URL


Email

d-takegawa@tokushima-u.ac.jp


Sponsor or person

Institute

Tokushima University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

ASO International Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Tokushima University Hospital

Address

2-50-1 Kuramotocho, Tokushima

Tel

088-633-7958

Email

brinshoshienk@tokushima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 01 Month 20 Day

Date of IRB

2024 Year 04 Month 30 Day

Anticipated trial start date

2024 Year 02 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 03 Month 04 Day

Last modified on

2024 Year 09 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060817